Search results
Results from the WOW.Com Content Network
Metformin is the most popular anti-diabetic drug in the United States and one of the most prescribed drugs overall, with nearly 35 million prescriptions filled in 2006 for generic metformin alone. The biguanide class of anti-diabetic drugs originates from the French lilac ( Galega officinalis ), a plant known for several centuries to reduce the ...
G. officinalis is rich in galegine, a substance with blood glucose-lowering activity and the foundation for the discovery of metformin, [6] a treatment for managing symptoms of diabetes mellitus. [7] In ancient herbalism, goat's-rue was used as a diuretic. [8] It can be poisonous to mammals, but is a food for various insects. [4]
A 2017 review found that people with diabetes who were taking metformin had lower all-cause mortality. [231] They also had reduced cancer and cardiovascular disease compared with those on other therapies. [231] In people without diabetes, metformin does not appear to reduce the risk of cancer and cardiovascular disease. [237]
Metformin is a member of the biguanide class, improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.
Download as PDF; Printable version; In other projects Wikidata item; ... French lilac is a common name for several plants and may refer to: Syringa vulgaris of the ...
Although it must be used with caution in patients with impaired liver or kidney function, Metformin, a biguanide, has become the most commonly used agent for type 2 diabetes in children and teenagers. Among common diabetic drugs, Metformin is the only widely used oral drug that does not cause weight gain.
Therefore, they are effective in Type 2 diabetics; and in Type 1 diabetes when used in conjunction with insulin therapy. [citation needed] Mainly used in Type II diabetes, metformin is considered to increase insulin sensitivity in vivo, resulting in reduced plasma glucose concentrations, increased glucose uptake, and decreased gluconeogenesis.
In the United States, sitagliptin/metformin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. [5] [6]In the European Union, sitagliptin/metformin is indicated as an adjunct to diet and exercise to improve glycemic control in people with type 2 diabetes; in combination with a sulfonylurea as an adjunct to diet and exercise "in people ...